Family · Pharmaceutical analytical standards
Pergolide
An ergoline-based dopamine agonist, sharing the structure of the ergot alkaloids: patented in 1978 and approved in 1989 for Parkinson's disease, it was withdrawn from the human market in the United States in 2007. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?Today it is also used in veterinary medicine: in horses it treats pituitary pars intermedia dysfunction, known as 'equine Cushing's'.
No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
